Douglas Kerr Generation Bio Co. (GBIO) insider trading activity

Douglas Kerr is CHIEF MEDICAL OFFICER of Generation Bio Co.. Currently has a direct ownership of 385,628 shares of GBIO, which is worth approximately $428,047. The most recent transaction as insider was on Jan 29, 2024, when has been sold 1,476 shares (Common Stock) at a price of $1.9 per share, resulting in proceeds of $2,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 386K

0% 3M change

4.11% 12M change

Total Value Held $428,047

Douglas Kerr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2024	SELL Payment of exercise price or tax liability	$2,804 $1.9 p/Share	1,476 Reduced 0.38%	385,628 Common Stock
Jan 29 2024	BUY Exercise of conversion of derivative security	-	5,021 Added 1.28%	387,104 Common Stock
Jan 15 2024	SELL Payment of exercise price or tax liability	$9,353 $1.91 p/Share	4,897 Reduced 1.27%	382,083 Common Stock
Jan 15 2024	BUY Exercise of conversion of derivative security	-	14,131 Added 3.55%	384,403 Common Stock
Oct 15 2023	SELL Payment of exercise price or tax liability	$7,072 $3.24 p/Share	2,183 Reduced 0.59%	370,404 Common Stock
Oct 15 2023	BUY Exercise of conversion of derivative security	-	7,437 Added 1.96%	372,587 Common Stock
Jul 15 2023	SELL Payment of exercise price or tax liability	$11,089 $5.08 p/Share	2,183 Reduced 0.59%	365,150 Common Stock
Jul 15 2023	BUY Exercise of conversion of derivative security	-	7,437 Added 1.98%	367,333 Common Stock
Apr 15 2023	SELL Payment of exercise price or tax liability	$9,823 $4.5 p/Share	2,183 Reduced 0.61%	356,780 Common Stock
Apr 15 2023	BUY Exercise of conversion of derivative security	-	7,437 Added 2.03%	358,963 Common Stock
Jan 15 2023	SELL Payment of exercise price or tax liability	$13,147 $5.1 p/Share	2,578 Reduced 0.73%	351,526 Common Stock
Jan 15 2023	BUY Exercise of conversion of derivative security	-	7,438 Added 2.06%	354,104 Common Stock
Oct 15 2022	SELL Payment of exercise price or tax liability	$12,252 $5.61 p/Share	2,184 Reduced 0.63%	344,801 Common Stock
Oct 15 2022	BUY Exercise of conversion of derivative security	-	7,438 Added 2.1%	346,985 Common Stock
Jul 15 2022	SELL Payment of exercise price or tax liability	$31,355 $7.18 p/Share	4,367 Reduced 1.27%	339,547 Common Stock
Jul 15 2022	BUY Exercise of conversion of derivative security	-	14,876 Added 4.15%	343,914 Common Stock
Jul 08 2021	SELL Open market or private sale	$88,618 $25.19 p/Share	3,518 Reduced 1.07%	326,558 Common Stock
Jul 08 2021	BUY Exercise of conversion of derivative security	$18,153 $5.16 p/Share	3,518 Added 1.05%	330,076 Common Stock
Apr 05 2021	SELL Open market or private sale	$426,382 $30.3 p/Share	14,072 Reduced 4.13%	326,558 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	$72,612 $5.16 p/Share	14,072 Added 3.97%	340,630 Common Stock
Mar 05 2021	SELL Open market or private sale	$369,445 $32.79 p/Share	11,267 Reduced 3.34%	326,558 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	$51,716 $4.59 p/Share	11,267 Added 3.23%	337,825 Common Stock
Feb 08 2021	SELL Open market or private sale	$378,008 $33.55 p/Share	11,267 Reduced 3.34%	326,558 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	$51,716 $4.59 p/Share	11,267 Added 3.23%	337,825 Common Stock
Jan 11 2021	SELL Open market or private sale	$315,589 $28.01 p/Share	11,267 Reduced 3.34%	326,558 Common Stock

Also insider at

DYN

Dyne Therapeutics, Inc. Healthcare

Chief Medical Officer

Douglas Kerr

CHIEF MEDICAL OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Generation Bio Co. insider buys or sells GBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Generation Bio Co.

Track Activities on GBIO

Account